Work

Anifrolumab for Adolescent Discoid Lupus Erythematosus

Year: 2023

Type: article

Abstract: This case series describes the outcomes among adolescent patients with systemic lupus erythematosus and refractory discoid lupus erythematosus treated with anifrolumab.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2023.38200

Authors: Katharina S. Shaw, Ahmad Rajeh, Todd Le, Philip J. Kahn, Vikash S. Oza, Lisa M. Arkin, Ruth Ann Vleugels

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, Brigham and Women's Hospital, Harvard University, University of Wisconsin–Madison, NYU Langone Health, New York University, Boston Children's Hospital

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

OpenAlex ID: W4387729679

FWCI: 4.193

Cites: 4

Cited by: 24

Related to: 10